Add Yahoo as a preferred source to see more of our stories on Google. There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in ...

Amyotrophic lateral sclerosis remains difficult to diagnose and is frequently identified after substantial disease progression, underscoring the need for earlier recognition and expanded therapeutic ...

New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...

Please provide your email address to receive an email when new articles are posted on . The treatment group logged longer times to four disease-progression milestones compared with controls. At 2 ...

Eric Dane offered insight into the progression of his ALS diagnosis before his death at age 53. Dane revealed his health battle in April 2025. ALS stands for amyotrophic lateral sclerosis, a nervous ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a neurodegenerative disease that affects the neurons in the brain and spinal cord. In the United States alone there are ...

New ALS drug enters human trials after reversing a key protein in animals and could change the future of treatment.

In a June 2025 interview, Dane shared that his ALS symptoms had started about a year and a half prior — late 2023 or early ...

There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...